Results 1 to 10 of about 7,676,359 (302)
Interleukin 6 in Hyposmia [PDF]
JAMA Otolaryngology–Head & Neck Surgery, 2013 Olfaction is a complex sensory process that has not been fully studied. Elevated plasma levels of interleukin 6 (IL-6) have been found in patients with several acute and chronic diseases but have not been reported in patients with smell loss (hyposmia).To determine IL-6 levels in patients with hyposmia.Retrospective study.
Robert I, Henkin +2 more
openaire +2 more sources
Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting
Journal of Cachexia, Sarcopenia and Muscle, 2022 Background Sepsis and inflammation can cause intensive care unit‐acquired weakness (ICUAW). Increased interleukin‐6 (IL‐6) plasma levels are a risk factor for ICUAW. IL‐6 signalling involves the glycoprotein 130 (gp130) receptor and the JAK/STAT‐pathway,
Lukas Zanders +13 more
doaj +1 more source
Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease [PDF]
Blood, 1991 Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute- phase proteins in liver cells. It has been suggested that IL-6 is involved in the pathogenesis of several diseases by autocrine or paracrine pathways.
M, Jücker +9 more
openaire +3 more sources
Interleukin-6 Promoter Haplotypes and Interleukin-6 Cytokine Responses [PDF]
Shock, 2003 Genetic variations contribute to differences in the inflammatory response and are markers for disease risk and outcomes. We studied three single-nucleotide polymorphisms (-597 G-->A, -572 G-->C, and -174 G-->C) in the IL-6 promoter to determine associations with ex vivo LPS-stimulated IL-6 production by leukocytes.
Fernando A, Rivera-Chavez +3 more
openaire +2 more sources
Detection of Salivary Interleukin 2 and Interleukin 6 in Patients With Burning Mouth Syndrome
Mediators of Inflammation, 2006 The etiology of BMS remains unknown. Role of various cytokines has been implicated in the development of BMS. The aim of this study was to evaluate levels of salivary IL-2 and IL-6 in patients with BMS, compared with age-matched healthy volunteers ...
Daria Simcic +5 more
doaj +2 more sources
Correlation Between Interleukin 6 and Interleukin 10 in Acute Myocardial Infarction
Biomolecules & Biomedicine, 2009 The aim of this study was to analyze (i) ratios between pro-inflammatory cytokines interleukin 6 (IL-6), interleukin 1 (IL-1), tumour necrosis factor α (TNF-α) and anti-inflammatory cytokine interleukin 10 (IL-10) in patients with acute myocardial ...
Larisa Dizdarević-Hudić +9 more
doaj +1 more source
Научно-практическая ревматология, 2023 Aim. Switching to another biologic with the same mode of action provides greater opportunity for long-term management of patients with rheumatoid arthritis (RA).
A. A. Baranov +16 more
doaj +1 more source
Interleukin‐6: a cytokine to forget [PDF]
The FASEB Journal, 2004 ABSTRACT It is known that proinflammatory cytokines such as interleukin‐6 (IL‐6) are expressed in the central nervous system (CNS) during disease conditions and affect several brain functions including memory and learning.
Balschun, D. +6 more
openaire +3 more sources
Salivary Interleukin 6 and Sialic acid in Periodontitis
Brazilian Journal of Oral Sciences, 2018 Aim: Periodontitis is the major multi –factorial chronic infectious oral diseases in dentate people. Sialic acid regulates innate immunity response that release cytokines.
Jwan Ibrahim Jawzali
doaj +1 more source
Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy
Human Vaccines & Immunotherapeutics, 2020 The interleukin 6 (IL6) family of proteins regulate important cellular processes and act through a variety of signaling pathways via a shared gp130 receptor.
Anissa A. Widjaja +2 more
doaj +1 more source